Innovent Biologics (suzhou) Co. Ltd.

This early-stage study tested a single dose of a new drug called IBI3002 in 52 healthy volunteers and people with mild-to-moderate asthma. The main goal was to see if the drug is safe and how the body processes it. Researchers measured side effects and drug levels in the blood ov…